RHY 5.26% 5.4¢ rhythm biosciences limited

Future Announcements, page-21

  1. 468 Posts.
    lightbulb Created with Sketch. 97
    Even if Colostat was the 'disruptive technology' they are claiming, which it is no longer due to the widespread availability of DNA tests; it wouldnt matter. This management has no hope in hell, given their track record, of launching anything. Lets face it, Musk has a much greater chance of getting to Mars on his rocket that blew up this morning, than Colostat has of ever becomming a success. Buy away!
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.